Edition:
United Kingdom

People: China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

4.45HKD
18 Jul 2019
Change (% chg)

HK$0.03 (+0.68%)
Prev Close
HK$4.42
Open
HK$4.40
Day's High
HK$4.47
Day's Low
HK$4.31
Volume
1,322,000
Avg. Vol
1,509,633
52-wk High
HK$5.73
52-wk Low
HK$3.26

Shi, Xiaofeng 

Mr. Shi Xiaofeng is Director and General Manager of Grand Pharm (China), a subsidiary of China Grand Pharmaceutical and Healthcare Holdings Ltd. Mr. Shi is responsible for overseeing the entire operations and management of Grand Pharm (China), he has over 20 years of experience in the pharmaceutical industry management. Mr Shi used to work for Schering-Plough and Pharmacia as senior management before joining the Group. Mr Shi holds a medical degree from Medical School of Southeast University and a EMBA degree at China Europe International Business School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Chengwei Liu

50,000

Yan Shao

1,516,000

Bo Hu

50,000

Zhanqi Niu

--

Yonghua Feng

--

Xiaofeng Shi

--
As Of  31 Dec 2014